| abstract |
The present invention relates to novel therapies and therapeutic targets for treating and reducing the symptoms associated with tumors of the central nervous system (CNS). In particular, the present invention provides novel glioma therapies comprising administering agents that inhibit the coagulation process and, more particularly, inhibiting one or more of the various factors involved therein. For example, the present invention provides methods of treating gliomas comprising administering a therapeutically effective amount of an antithrombin agent (e.g., ARGATROBAN) to a subject. |